Survival rate and complications after different types of pelvic exenteration for gynecological cancer

被引:2
作者
Nedyalkov, K. [1 ]
Magunska, N. [2 ]
Bechev, B. [1 ]
Kostov, I [1 ]
机构
[1] FSOGH St Sofia, Mihalaki Tashev 2 St, Sofia 1330, Bulgaria
[2] OB Gyn Hosp Dr Shterev, Sofia, Bulgaria
关键词
Pelvic exenteration; Cervical cancer; Ovarian cancer; Endometrial cancer; Complications; URINARY-DIVERSION; RECURRENT; EXPERIENCE; MALIGNANCIES; MANAGEMENT; MORBIDITY; ONCOLOGY;
D O I
10.12892/ejgo4285.2019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pelvic exenteration (PE) is an operative method for one-moment removal of pelvic organs, including reproductive tract, bladder, and rectosidgmoid. It is most commonly indicated in gynecologic oncology for treatment of locally advanced cancer or recurrence with central localization. The purpose of this study was to evaluate survival rate and complications in different types of PEs performed for cervical, uterine, and ovarian cancer and to report the authors' experience. Patients undergoing PE for cervical, uterine, and ovarian cancer (n=46) were prospectively collected. Operative techniques types included total PE (n=9), anterior PE (n=14), posterior PE (n=7), and modified posterior PE (n=16). Overall intra-and postoperative complication rate was 34.8% for the series. Mild complications occurred in 28.2% and severe complications in 6.5%. Perioperative mortality was 2.2%. PE in patients with advanced stage of gynecological malignancies was associated with high complication rate and high perioperative mortality and morbidity. Therefore, operative techniques with proven safety should be used. Creating ureter anastomosis with incontinent urinary conduit from terminal ileum can be considered as such technique. Although all factors that impact negative on quality of life, PE remains an alternative for extending life of these types of patients
引用
收藏
页码:69 / 73
页数:5
相关论文
共 31 条
[1]   Pelvic exenteration for recurrent endometrial cancer [J].
Barakat, RR ;
Goldman, NA ;
Patel, DA ;
Venkatraman, ES ;
Curtin, JP .
GYNECOLOGIC ONCOLOGY, 1999, 75 (01) :99-102
[2]   Pelvic exenteration in gynecologic oncology: A single institution study over 20 years [J].
Benn, T. ;
Brooks, R. A. ;
Zhang, Q. ;
Powell, M. A. ;
Thaker, P. H. ;
Mutch, D. G. ;
Zighelboim, I. .
GYNECOLOGIC ONCOLOGY, 2011, 122 (01) :14-18
[3]   Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA [J].
Berek, JS ;
Howe, C ;
Lagasse, LD ;
Hacker, NF .
GYNECOLOGIC ONCOLOGY, 2005, 99 (01) :153-159
[4]  
BRICKER EM, 1950, SURG CLIN N AM, V30, P1511
[5]  
BRUNSCHWIG A, 1948, CANCER-AM CANCER SOC, V1, P177, DOI 10.1002/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO
[6]  
2-A
[7]   OMENTAL SLING FOR MANAGEMENT OF PELVIC FLOOR FOLLOWING EXENTERATION [J].
BUCHSBAU.HJ ;
WHITE, AJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 117 (03) :407-412
[8]  
DEVEREUX DF, 1980, J SURG ONCOL, V14, P227, DOI 10.1002/jso.2930140307
[9]   Total Pelvic Exenteration for Gynecologic Malignancies [J].
Diver, Elisabeth J. ;
Rauh-Hain, J. Alejandro ;
del Carmen, Marcela G. .
INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2012, 2012
[10]  
EISENKOP SM, 1991, OBSTET GYNECOL, V78, P879